Executive Summary

Abbott FreeStyle remains the category's coverage leader in August 2026, holding a 57.4% valid recommendation coverage rate across qualified AI/search observations. The gap to the next brand narrowed slightly as Ascensia CONTOUR moved to 42.1%, leaving a 15.3-point separation between first and second place, down from a 17.5-point gap in July 2026. Prodigy Diabetes Care was the only brand whose coverage moved beyond normal month-to-month variation, rising from 0.5% to 2.7% valid recommendation coverage, a 2.2-point gain. The rest of the field, including the category leader, shifted within the range of ordinary variation.

Beneath the coverage numbers, rank-one placement also moved. Ascensia CONTOUR gained the top recommendation slot in 29.2% of observations, up from 24.6% in July 2026, while Abbott FreeStyle's rank-one rate fell from 12.2% to 7.1%. Ascensia CONTOUR now leads the category in rank-one placement even though its overall coverage rate remains second to Abbott FreeStyle.

Against the July 2026 baseline, the category leader gave back 4.3 points of coverage, yet Abbott FreeStyle retained a commanding lead over the rest of the field.

Each monthly run begins with 800 prompt-surface observations (524 unique questions in July 2026; 558 in August 2026) across the benchmark's defined AI/search surface universe. Of those, 595 mentioned a tracked brand or competitor in July, and 593 in August; 586 were relevant and 9 irrelevant in July, compared with 582 relevant and 11 irrelevant in August. The public metrics use the 394 qualified observations from July 2026 and 366 from August 2026 that survive both qualification stages.

Key Findings

Benchmark Context

The report separates the raw collection universe from the qualified analysis set. Brand-level recommendation percentages are calculated within the qualified benchmark set.

These benchmark-wide figures set the context for the individual brand comparisons that follow.

Benchmark-Level Metrics

AI Recommendation Trend

August 2026 preserves the category order established in July 2026, with the gap between the top two brands narrowing slightly.

Category Coverage Comparison

Abbott FreeStyle holds a 15.3-point lead over Ascensia CONTOUR in August 2026, narrowed from a 17.5-point gap in July 2026. Prodigy Diabetes Care's rise is the only movement across the six tracked brands that exceeded normal month-to-month variation; the rest of the field shifted within that range.

What Changed This Month

Trividia Health: Coverage declines while presence rises

Trividia Health's valid recommendation coverage fell from 1.0% in July 2026 to 0.3% in August 2026, a 0.7-point decline within normal variation. In absolute terms, the brand received 1 valid recommendation out of 366 qualified observations in August, down from 4 out of 394 in July. Raw mention presence moved in the opposite direction, rising from 3.5% to 4.4%, while net sentiment fell from 0.4 to 0.1. The brand earned no rank-one or top-three placements in August.

Abbott FreeStyle records 57.4% valid recommendation coverage, while Trividia Health stands at 0.3%. The more important issue is that Trividia's rising mention presence is not converting into recommendation outcomes: the brand is appearing in more AI responses while being recommended less often. The current benchmark does not establish why that gap exists, making the mechanism behind the recommendation shortfall the immediate issue to diagnose.

Highest-priority diagnostic: What are AI systems saying when they mention Trividia without recommending it, and which prompts, surfaces, evidence sources, or competitor outcomes are responsible for the measured recommendation gap?

Abbott FreeStyle: Leadership intact, rank-one position weakens

Abbott FreeStyle's valid recommendation coverage declined from 61.7% in July 2026 to 57.4% in August 2026, a 4.3-point drop that stayed within normal variation. Despite the decline, the brand remains the category leader with a 15.3-point margin over Ascensia CONTOUR.

The more consequential shift sits in placement quality. Abbott FreeStyle's rank-one recommendation rate fell from 12.2% to 7.1%, a 5.1-point decline that stands as the largest single movement in the category this month. Top-three placement also eased from 54.3% to 49.7%.

The distinction the reader should notice: Abbott FreeStyle remains the most frequently recommended brand overall, but it is holding top position in fewer AI answers. The brand's raw mention presence also slipped from 95.2% to 91.8%.

Highest-priority diagnostic: Which specific prompts shifted from Abbott FreeStyle to another brand as the top recommendation, and which competitor captured those top slots?

Ascensia CONTOUR: Fewer recommendations, stronger top placement

Ascensia CONTOUR's coverage declined from 44.2% in July 2026 to 42.1% in August 2026, a 2.1-point drop within normal variation. The brand's raw mention presence also eased from 53.5% to 50.8%.

Beneath the coverage decline, placement quality moved higher. Ascensia CONTOUR's rank-one rate rose from 24.6% to 29.2%, a 4.6-point gain. The brand now leads the category in rank-one placement, ahead of Abbott FreeStyle's 7.1%.

The distinction the reader should notice: Ascensia CONTOUR is being recommended less often overall but is claiming the top spot more frequently when it is recommended. The brand's average recommended rank moved from 1.8 to 1.6, consistent with that pattern.

Highest-priority diagnostic: Which AI surfaces and prompt types are associated with the improvement in top placement, and is the coverage decline concentrated in specific surfaces?

Prodigy Diabetes Care: A rise from a small base

Prodigy Diabetes Care's valid recommendation coverage rose from 0.5% in July 2026 to 2.7% in August 2026, a 2.2-point gain, the only coverage movement this month large enough to register as a significant riser. The brand's top-three rate moved from 0.0% to 2.2%. It remains the category's smallest presence at 10 valid recommendations out of 366 qualified observations.

Raw mention presence climbed from 1.5% to 3.5%, and net sentiment moved from 0.2 to 0.8. The brand recorded no rank-one recommendations in either month.

The distinction the reader should notice: Prodigy's movement is real but small in absolute terms. Ten valid recommendations across 366 observations is a thin base from which to draw strong conclusions, though the direction is consistent across coverage, placement, and presence.

Highest-priority diagnostic: Which prompts and surfaces account for the new valid recommendations, and what evidence sources are AI systems citing when they surface Prodigy?

Buyer-Intent Interpretation

In August 2026, all 366 qualified observations fell into the Brand Recommendation cluster. No observations qualified in the Pricing & Value or Multi-Brand Comparison clusters, which means the public benchmark cannot yet answer questions about how AI positions brands on price, value, or head-to-head comparison. The available evidence speaks to which brands AI recommends, and how prominently, but not to the commercial reasoning behind those recommendations.

Brand Opportunity Summary

The benchmark identifies where attention is warranted across the category; a company-level analysis is needed to explain why these patterns are emerging.

Evidence Behind the Benchmark

The aggregate metrics are built from prompt-level observations that capture the query, the AI surface, the recommendation outcome, placement rank, sentiment, and citations where exposed. Company-level analysis can go deeper into prompt patterns, competitor displacement, surface-level differences, and the evidence sources that shape AI answers. Source presence in an AI answer is not automatically treated as proof of causation.

About This Benchmark

This report is part of the LLM Authority Index AI Market Discovery research program.

• AI Industry Market Discovery Methodology
• AI Industry Market Discovery Metrics
• AI Industry Market Discovery Standards

Report-Specific Interpretation Notes

• Small-count movements: Prodigy Diabetes Care's rise is based on 10 valid recommendations in August 2026; Trividia Health's decline is based on 1 valid recommendation. Interpret these with caution.
• Qualified denominator: All percentages use the qualified observation counts of 394 (July) and 366 (August), not the raw collection of 800 prompts per month.
• Directional analysis: Month-over-month movements identify changes worth investigating. They do not by themselves establish the cause of those changes.

Next Step

The Public Benchmark Shows Where a Brand Is Winning or Losing. A Company-Level Audit Shows Why.

Beneath the aggregate percentages sit the questions that matter for commercial positioning. Which high-intent prompts is a brand winning, and which is it losing? When a brand is not recommended, which competitor takes the slot? What attributes do AI systems associate with each option, and which external sources are shaping those associations? The public benchmark points to the pattern, but it does not explain the mechanism behind it.

A company-specific AI visibility audit maps prompt-level patterns, surface-level differences, competitor displacement, ranking outcomes, sentiment, and evidence-source influence into a prioritized visibility strategy. It answers the why behind the what.

Request an AI visibility audit